Efficacy and safety of intravitreal anti-VEGF for myopic choroidal neovascularization
AIM: To report the 24mo outcomes of vascular endothelial growth factor (VEGF) inhibitors for myopic choroidal neovascularization (mCNV) in routine clinical practice and simultaneously evaluated the real-world safety. METHODS: The patients who received intravitreal injections of VEGF inhibitors of ei...
Saved in:
| Main Authors: | Jing-Yao Liu, Ju-Ping Liu, Xiao-Rong Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2025-09-01
|
| Series: | International Journal of Ophthalmology |
| Subjects: | |
| Online Access: | http://ies.ijo.cn/en_publish/2025/9/20250909.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Choroidal Osteoma with Choroidal Neovascularization and Focal Choroidal Excavation
by: Rajwinder Kaur, et al.
Published: (2021-10-01) -
A New Anti-VEGF Inhibitor, Aflibercept: Treatment Outcomes Of Neovascular Macular Degeneration Refractory To Other Anti-VEGF Agents
by: Kiran Turaka
Published: (2014-04-01) -
Optical Coherent Tomography-Angiography in the Research of Myopia Complicated by Choroidal Neovascularization
by: E. A. Drozdova, et al.
Published: (2020-09-01) -
Pediatric peripapillary choroidal neovascularization secondary to ocular sarcoidosis: a long-term follow-up case
by: Yuan Zong, et al.
Published: (2025-07-01) -
Effects of orthokeratology lenses on choroidal thickness and choriocapillaris perfusion in myopic children
by: Lulu Wang, et al.
Published: (2025-08-01)